339 related articles for article (PubMed ID: 16828072)
1. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
2. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Khai NC; Maruyama R; Ogino A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2006 Jan; 113(4):535-43. PubMed ID: 16449733
[TBL] [Abstract][Full Text] [Related]
3. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
[TBL] [Abstract][Full Text] [Related]
4. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-related cardiac gene expression early after murine myocardial infarction.
Vandervelde S; van Luyn MJ; Rozenbaum MH; Petersen AH; Tio RA; Harmsen MC
Cardiovasc Res; 2007 Mar; 73(4):783-93. PubMed ID: 17208206
[TBL] [Abstract][Full Text] [Related]
6. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
8. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.
Rui T; Feng Q; Lei M; Peng T; Zhang J; Xu M; Abel ED; Xenocostas A; Kvietys PR
Cardiovasc Res; 2005 Feb; 65(3):719-27. PubMed ID: 15664399
[TBL] [Abstract][Full Text] [Related]
12. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
14. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
[TBL] [Abstract][Full Text] [Related]
15. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart.
Li M; Georgakopoulos D; Lu G; Hester L; Kass DA; Hasday J; Wang Y
Circulation; 2005 May; 111(19):2494-502. PubMed ID: 15867183
[TBL] [Abstract][Full Text] [Related]
16. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
17. Chronic erythropoietin treatment decreases post-infarct myocardial damage in rats without venous thrombogenic effect.
Prunier F; Pottier P; Clairand R; Mercier A; Hajjar RJ; Planchon B; Furber A
Cardiology; 2009; 112(2):129-34. PubMed ID: 18596374
[TBL] [Abstract][Full Text] [Related]
18. IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart.
Gurantz D; Cowling RT; Varki N; Frikovsky E; Moore CD; Greenberg BH
J Mol Cell Cardiol; 2005 Mar; 38(3):505-15. PubMed ID: 15733910
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.
Lu MJ; Chen YS; Huang HS; Ma MC
Life Sci; 2012 May; 90(19-20):776-84. PubMed ID: 22521289
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
